| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |